Effective Response Rates of Lenalidomide and Rituximab as Initial Treatment of ... Monthly Prescribing Reference SAN DIEGO, CA—Investigators at the 53 rd American Society of Hematology Annual Meeting and Exposition presented study data demonstrating high response rates of lenalidomide and rituximab for the initial treatment of chronic lymphocytic leukemia (CLL). ... |
